Figure Gallery

Expression Pattern Search Results for myb

(247 figures with expression from 126 publications)
Publication	Data	Fish	Condition	Stage Range	Anatomy
Dunn et al., 2017	Fig. 4	AB + MO3-fer	standard conditions	Prim-5	whole organism
	Fig. 6	AB AB + MO3-fer	standard conditions	Prim-5	blood island hematopoietic cell
Genthe et al., 2017	Fig. 1	WT rspo1^y135/y135	standard conditions	Prim-25	dorsal aorta hematopoietic stem cell
	Fig. 5	WT WT + MO3-rspo1	standard conditions	Prim-25	dorsal aorta hematopoietic stem cell
He et al., 2017	Fig. 5	TU cdkn2aip^{cas009/cas009} tp53^zdf1/zdf1 TU + MO1-cdkn2aip cdkn2aip^{cas009/cas009} + MO7-tp53 tp53^zdf1/zdf1 + MO1-cdkn2aip	control	Prim-15	hematopoietic stem cell
Kasper et al., 2017	Fig. 5	AB mir223^ya303/ya303 mir223^ya304/ya304	control	Prim-15 to Day 6	hematopoietic multipotent progenitor cell intermediate cell mass of mesoderm hematopoietic multipotent progenitor cell thymus hematopoietic multipotent progenitor cell
Lawir et al., 2017	Fig. 4	WT zbtb17^{t20463/t20463}	standard conditions	Prim-25	hematopoietic stem cell
Lu et al., 2017	Fig. 2	AB twu104Tg (AB)	standard conditions	20-25 somites to Day 5	whole organism
Theodore et al., 2017	Fig. 4	WT fn1a^tl43c/tl43c	control chemical treatment by environment: N(2)-([biphenyl]-4-ylsulfonyl)-N-hydroxy-N(2)-isopropoxy-D-valinamide	Protruding-mouth	hematopoietic multipotent progenitor cell ventral wall of dorsal aorta
	Fig. 7	WT mik1Tg	heat shock	Protruding-mouth	hematopoietic system posterior region thymus
	Fig. 2	WT WT + MO1-mmp2 WT + MO4-mmp9	control chemical treatment by environment: N(2)-([biphenyl]-4-ylsulfonyl)-N-hydroxy-N(2)-isopropoxy-D-valinamide chemical treatment by environment: prinomastat hydrochloride chemical treatment by environment: MMP9 inhibitor I	Prim-25	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
	Fig. 5	WT WT + MO1-mmp2 WT + MO4-mmp9	control chemical treatment by environment: N(2)-([biphenyl]-4-ylsulfonyl)-N-hydroxy-N(2)-isopropoxy-D-valinamide chemical treatment by environment: MMP9 inhibitor I	Protruding-mouth	hematopoietic system posterior region ventral wall of dorsal aorta
	Fig. 6	WT	control chemical treatment by environment: MMP9 inhibitor I	Protruding-mouth to Day 5	hematopoietic multipotent progenitor cell hematopoietic system posterior region thymus
Tu et al., 2017	Fig. 3	cku1Tg	control heat shock	Prim-5 to Long-pec	blood island hematopoietic stem cell intermediate cell mass of mesoderm hematopoietic stem cell ventral wall of dorsal aorta hematopoietic stem cell
Xu et al., 2017	Fig. 2	WT	standard conditions	Prim-5	hematopoietic multipotent progenitor cell
Xue et al., 2017	Fig. 2	WT klf6a^{ioz102/ioz102}	standard conditions	Day 4 to Day 5	hematopoietic cell hematopoietic stem cell whole organism posterior region
	Fig. 3	TU WT klf6a^{ioz102/ioz102} TU + MO1-klf6a	standard conditions control	Long-pec to Pec-fin	hematopoietic stem cell
	Fig. 6	TU TU + MO2-ccl25b	standard conditions	Pec-fin	hematopoietic stem cell
	Fig. 1	TU	standard conditions	Prim-25 to Day 4	hematopoietic stem cell
Zhang et al., 2017	Fig. 2	WT rb1^sm11/sm11	control	Protruding-mouth to Day 5	thymus anatomical region thymus hematopoietic stem cell
Chen et al., 2016	Fig. 1	WT WT + MO1-cyp2aa3,cyp2aa9	standard conditions	Prim-25	dorsal aorta hematopoietic stem cell hematopoietic stem cell
	Fig. 5	WT WT + MO1-cyp2aa3,cyp2aa9	standard conditions chemical treatment by environment: forskolin	Prim-25	hematopoietic stem cell
Fujii et al., 2016	Fig. 6	WT WT + CRISPR1-smyd5	standard conditions	Prim-15	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 5	WT WT + MO2-smyd5 WT + MO3-smyd5	standard conditions control	Prim-15	ventral wall of dorsal aorta hematopoietic stem cell
Gao et al., 2016	Fig. 4	WT WT + MO1-gpr65 WT + MO2-gpr65	control	Prim-25	hematopoietic multipotent progenitor cell